Evidence map›Paper›PMID 27345029›Full record

ArticleAntioxidants & redox signaling2016

TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone.

Franziska Sotzny, Eileen Schormann, Ina Kühlewindt, Annett Koch, Anja Brehm, Raphaela Goldbach-Mansky, Kate E Gilling, Elke Krüger

Abstract read
In one paragraph

Article in Antioxidants & redox signaling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Nrf1 Reduces COX-2 Expression and Maintains Cellular Homeostasis After Cerebral Ischemia/Reperfusion By Targeting IL-6/TNF-α Protein Production.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Franziska Sotzny1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Eileen Schormann1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Ina Kühlewindt1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Annett Koch1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Anja Brehm1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Raphaela Goldbach-Mansky2 Translational Autoinflammatory Disease Section , NIAMS, NIH, Bethesda, Maryland.
Kate E Gilling1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Elke Krüger1 Charité-Universitätsmedizin Berlin, Institut für Biochemie , Berlin, Germany .
Charité - Universitätsmedizin Berlin · DENational Institutes of Health · US

Funding

Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory DiseasesZIAAI001220 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GOLDBACH-MANSKY, RAPHAELA · 2017 to 2025
$22.3M
Pathogenesis and treatment studies in patients with NOMID and related diseasesZIAAR041138 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI GOLDBACH-MANSKY, RAPHAELA · 2009 to 2016
$8.6M
6 · The paper itself

Abstract

aimsPrecise regulation of cellular protein degradation is essential for maintaining protein and redox homeostasis. The ubiquitin proteasome system (UPS) represents one of the major degradation machineries, and UPS disturbances are strongly associated with neurodegeneration. We have previously shown that the transcription factor TCF11/Nrf1 induces antioxidant response element-mediated upregulation of UPS components in response to proteotoxic stress. Knockout of TCF11/Nrf1 is embryonically lethal, and therefore, the present investigation describes the role of oxidative stress in regulating TCF11/Nrf1-dependent proteasome expression in a model system relevant to Parkinson's disease.

resultsUsing the human dopaminergic neuroblastoma cell line SH-SY5Y and mouse nigrostriatal organotypic slice cultures, gene and protein expression analysis and functional assays revealed oxidative stress is induced by the proteasome inhibitor epoxomicin or the mitochondrial complex I inhibitor rotenone and promotes the upregulation of proteasome expression and function mediated by TCF11/Nrf1 activation. In addition, we show that these stress conditions induce the unfolded protein response. TCF11/Nrf1, thus, has a cytoprotective function in response to oxidative and proteotoxic stress. Innovation and Conclusion: We here demonstrate that adaption of the proteasome system in response to oxidative stress is dependent on TCF11/Nrf1 in this model system. We conclude that TCF11/Nrf1, therefore, plays a vital role in maintaining redox and protein homeostasis. This work provides a vital insight into the molecular mechanisms of neurodegeneration due to oxidative stress by rotenone, and further studies investigating the role of TCF11/Nrf1 in the human condition would be of considerable interest. Antioxid. Redox Signal. 25, 870-885.

Indexed as

AnimalsCell DeathChild, PreschoolFemaleGene Expression RegulationHumansMiceModels, BiologicalNF-E2-Related Factor 1Nuclear Respiratory Factor 1OligopeptidesOxidative StressProteasome Endopeptidase ComplexProteasome InhibitorsProtein TransportReactive Oxygen SpeciesepoxomicinNFE2L1 protein, humanNF-E2-Related Factor 1Nuclear Respiratory Factor 1OligopeptidesProteasome Endopeptidase ComplexProteasome InhibitorsReactive Oxygen SpeciesRotenoneneurodegenerationoxidative stressproteasomerotenonetranscription factor TCF11/Nrf1ubiquitin

Identifiers

PMID27345029
PMCPMC6445217
OpenAlexW2558339860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.